Erudio Healtherudio.com
Drug
Temozolomide trials: what clinicians said in public
An HCP commentary report on 1 clinical trial studying temozolomide: SUPRAME. It covers what clinicians said in public about one trial, on podcasts, videos and posts, every statement linked to its source. Below them, 5 more trials with public commentary and no report yet.
| Trial | Indication | Phase | Statements | Sources | Size | Checked | Preview |
|---|---|---|---|---|---|---|---|
| SUPRAME NCT06743126 · Immatics US, Inc. | previously treated, unresectable or metastatic cutaneous melanoma | Phase 3 | 108 | 39 | Focused | Nov 20, 2026 | Preview |
| No report yetTrials with public commentary we haven't built a report for. Size is an estimate of the verified statements the commentary we've indexed so far will yield; final coverage is set when we build the report, within 24 hours of your confirmed order. You never pay more than quoted: a report delivered at a smaller size costs that size's price. Some can also be requested as a free preview. | |||||||
| CATNON NCT00626990 · European Organisation for Research and Treatment of Cancer - EORTC DeepView → | 1p/19q non-co-deleted anaplastic glioma | Phase 3 | Deep | View | |||
| GBM AGILE NCT03970447 · Global Coalition for Adaptive Research DeepView → | newly diagnosed and recurrent glioblastoma | Phase 2/Phase 3 | Deep | View | |||
| E2211 NCT01824875 · ECOG-ACRIN Cancer Research Group DeepView → | advanced pancreatic neuroendocrine tumors | Phase 2 | Deep | View | |||
| NRG-BN001 NCT02179086 · NRG Oncology StandardView → | newly diagnosed glioblastoma | Phase 2 | Standard | View | |||
| ComPareNET NCT05247905 · Alliance for Clinical Trials in Oncology FocusedView → | advanced well-differentiated pancreatic neuroendocrine tumors | Phase 2 | Focused | View | |||